BNT162 stands for various terms. Discover the full forms, meanings, and possible interpretations of BNT162 across different fields and industries.
BNT162b2 is a SARS-CoV-2 vaccine candidate developed by BioNTech and Pfizer and is currently in the Phase 3 study. It belongs to the RNA vaccines.
Last updated: